期刊文献+

冰黄凝胶治疗糖尿病足的作用及机理研究 被引量:10

Effects of BingHuang gelatum on diabetic foot and expressing mechanism of TNF-α and vWF
下载PDF
导出
摘要 目的观察冰黄凝胶干预治疗糖尿病足的作用,探讨糖尿病足大鼠血浆肿瘤坏死因子-α(TNF-α)和血管性假血友病因子(vWF)表达水平变化及其相关性。方法雄性Wistar大鼠65只,以链脲佐菌素和降温法制备糖尿病足模型。造模成功后大鼠随机分为4组:正常组、造模后未治疗组(A组)、西药治疗组(B组)、冰黄凝胶治疗组(C组)。15天后,取大鼠血浆,采用ELISA法检测大鼠血浆TNF-α和vWF的变化。结果造模后未治疗组大鼠血浆TNF-α(4.6±0 9)和vWF(1442.4±38 2)的表达水平明显高于正常对照组(2.5±0.5,461 0±28 4),差异具有显著性(P<0.01)。冰黄凝胶组TNF-a(2.5±0 7)和vWF(957.6±37.1)的表达水平明显低于西药治疗组(3.8±0 3,1031.8±35.3),差异具有显著性(P<0.01)。未治疗组大鼠血浆TNF-a与vWF的表达呈正相关(r=0.01)。结论冰黄凝胶干预治疗糖尿病足大鼠,可显著降低血浆TNF-a与vWF的表达,疗效明显优于西药。 Objective To observe BingHuang gelatum on diabetic foot and to probe into the relationship between the expression of TNF-α and vWF. Methods The model of diabetic foot was set up by a single intraperitoneal injection of streptozotocin(STZ). Sixty-five male wistar rats were randomly divided into 4 groups. 15th days later, the blood plasm was taken for assay of the expression of TNF-α and vWF. Results The results revealed that the expression of TNF-α and vWF in rats of diabetic foot model group(4.6 ± 0.9, 1442.4 ± 38.2) was significantly higher than that in the control group (2.5 ± 0.5,461.0 ± 28.4), P〈0.01. The expression of TNF-a and vWF in the rats of BingHuang gelatum group (2.5 ± 0.7, 957.6 ± 37.1) was significantly lower than that in western medicine treatment group(3.8 ± 0.3, 1031.8 ± 35.3, P〈0.01). Conclusion The effect of BingHuang gelatum on diabetic foot rats can significantly degrade the expression of TNF-α and vWF, The curative effect of BingHuang gelatum was better than western medicine.
机构地区 扬州大学医学院
出处 《实用临床医药杂志》 CAS 2009年第2期62-64,68,共4页 Journal of Clinical Medicine in Practice
基金 江苏省中医药科研资助项目(HL07110)
关键词 糖尿病足 冰黄凝胶 肿瘤坏死因子-Α 血管性假血友病因子 diabetic foot BingHuang gelatum TNF-α vWF
  • 相关文献

参考文献10

  • 1卜平,胡荣.治疗糖尿病足的中药湿性敷料及其制备方法[P].0719-2-C10421,2007,9.
  • 2陈群力,杨五彪,马灵筠.实验性糖尿病足大鼠模型的建立[J].河南预防医学杂志,2004,15(1):1-2. 被引量:19
  • 3郑鑫(综述),张凡(综述),张银刚(审校).糖尿病足治疗的进展[J].美中国际创伤杂志,2006,5(4):46-47. 被引量:3
  • 4Hotanmisigil G S, Shargill N S, Spiegelman B M. Adipose expression of tumor necrosis factol-alpha: direct role in obesit-linked insulin resistance[J]. Science, 1993, 259: 87.
  • 5Uyal K T, Wlesbrock S M, Marino M W, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-a function[J]. Nature, 1997, 389(6651): 610.
  • 6Nathalie D E, Rekeneire. Stephen B. Kritchevsky, et al. Diabetes, Hyperglycemia, and Inflammation in Older Individuals[J]. Diabetes Care, August 2006, 29(8) : 1902.
  • 7Aso Y, Fujiwara Y, Tayama K, et al. Elevation of von Willebrand factor in plasma diabetic patients with neuropathic foot ulceration[J]. Diabet Med, 2002, 19(1): 19.
  • 8Bloorngasden Z T. American Diabetes Association Annual Meeting, 1999. More on cardiovasculas disease[J]. Diabetes Care, 2000, 23(6): 845.
  • 9Smulders R A, Stehouwer C D, Schalkwijk C G, et al. Distinct associations of HbAIC and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellims[J]. Thromb Haemost, 1998, 80(1): 52.
  • 10Kessler L, Wiesel M L, Attali P, et al. von Willebrand factor in diabetic angiopathy. Diabetes Metab, 1998, 24(4): 327.

共引文献20

同被引文献177

引证文献10

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部